| Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
 | All procedures ( n = 632) | Severe pain ( n = 61) | Others ( n = 571) | P | OR (95%CI) | P |
Phase 1, n (%) | 184 | 30 (49%) | 154 (27%) | Â | Â | Â |
Phase 2, n (%) | 129 | 12 (20%) | 117 (20%) | 0.22 | Â | Â |
Phase 3, n (%) | 170 | 11 (18%) | 159 (28%) | 0.04 | 0.33 (0.11; 0.98) | 0.04 |
Phase 4, n (%) | 149 | 8 (13%) | 141 (25%) | 0.03 | 0.30 (0.12; 0.95) | 0.02 |
Age, median (IQR) | 63 (51; 71) | 64 (57; 76) | 63 (51; 71) | 0.16 | Â | Â |
Female gender, n (%) | 186 (29%) | 17 (28%) | 169 (30%) | 0.94 | Â | Â |
SAPS II, median (IQR) | 39 (29;41) | 39 (27;51) | 39 (30;51) | 0.48 | Â | Â |
Surgical admission, n (%) | 219 (35%) | 25 (41%) | 194 (34%) | 0.23 | Â | Â |
Intubation status, n (%) | 216 (34%) | 24 (39%) | 192 (34%) | 0.95 | Â | Â |
Sustained use of sedatives, n (%) | 114 (18%) | 10 (16%) | 104 (18%) | 0.69 | Â | Â |
RASS level, median (IQR) | 0 (-1; 0) | 0 (-1; 0) | 0 (-1; 0) | 0.31 | Â | Â |